Human Rantes Growth Factor ELISA Kit
search
  • Human Rantes Growth Factor ELISA Kit

Human CCL5 /Rantes ELISA Kit

Catalog # FM-E100119

Print

$760.00
Quantity

For research use only. Not for diagnostic or therapeutic use, or for human or veterinary use. Sold only to research institutions and qualified laboratory professionals. Not for sale to individuals for personal use.

Assay Range

15.6-1,000 pg/mL  

Sensitivity

3.0 pg/mL

Size

96T

Storage

Store at 2 - 8ºC. Keep reconstituted standard and detection Ab at -20 ºC

Assay Principle

Sandwich ELISA

Sample Volume

100 µL final volume, dilution factor varies on samples

Detection Method

Chromogenic

 

 

Kit Components

 

 1. Recombinant  Human CCL5 standard: 2 vials

 2. One 96-well plate coated with anti- Human CCL5  Ab

 3. Sample diluent buffer: 12 mL - 1

 4. Detection antibody: 130 µL, dilution 1:100

 5. Streptavidin-HRP: 130 µL, dilution 1:100

 6. Antibody diluent buffer: 12 mL x1   

 7. Streptavidin-HRP diluent buffer: 12 mL x1

 8. TMB developing agent: 10 mL x1

9. Stop solution: 10 mL x1

10. Washing solution (20x): 25 mL x1

 

 

Background

 

C-C motif chemokine 5 (CCL5), also known as RANTES (Regulated upon Activation, Normal T cell Expressed and presumably Secreted), EoCP, Eosinophil chemotactic cytokine, SIS-delta, Small-inducible cytokine A5, T cell-specific protein P228 (TCP228), is a member of the CC chemokine family. Human CCL5 is synthesized as a 91 amino acid (aa) precursor protein containing a 23 aa hydrophobic signal peptide and a 68 aa mature protein. Human CCL5 exhibits approximately 85% aa sequence identity with mouse CCL5.

CCL5 interacts with four G-protein coupled receptors: CCR1, CCR3, CCR4, and CCR5. CCL5 binding can activate a variety of context -dependent signaling cascades. For example, in T-cells, CCL5 causes elevations of intracellular Ca2+ and activation of focal adhesion kinase (FAK), protein kinase A, PI3-kinase, Rho GTPase, and JAK/STAT signaling pathways. The CCL5 receptor CCR5 also is the primary co-receptor for R5 variants of HIV-1. CCL5 and other CCR5 ligands, macrophage inflammatory protein (MIP)-1α and MIP-1β, can competitively inhibit CCR5/HIV-1 interaction and suppress viral infection in vitro. CCL5 has showed potent chemotactic activity for many different cell types including unstimulated CD4+/CD45RO+ memory T cells and stimulated CD4+ and CD8+ T cells with naive and memory phenotypes, NK cells, basophils, eosinophils, dendritic cells, mast cells, monocytes, and microglia. In addition, CCL5 can activate T cells, monocytes, neutrophils, NK cells, dendritic cells, and astrocytes. CCL5 knockout mice are unable to recruit leukocytes to sites of acute inflammation.

New